Sarcoma  >>  efatutazone (CS-7017)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
efatutazone (CS-7017) / Daiichi Sankyo
NCT02249949: Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

Completed
2
15
US
efatutazone
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), Daiichi Sankyo, Inc.
Liposarcoma
10/18
05/23

Download Options